Comparison of syntax score and syntax score II to predict “no reflow phenomenon” in patients with ST-segment elevation myocardial infarction

International Journal of Cardiovascular Imaging

Volumn 33, Issue 12, 2017, Pages 1883-1889

  Yesin, Mahmut ^a,g   Çağdaş, Metin ^b   Kalçık, Macit ^c   Uluganyan, Mahmut ^d   Efe, Süleyman Çağan ^e   Rencüzoğulları, İbrahim ^b   Karabağ, Yavuz ^b   Gürsoy, Mustafa Ozan ^f   Karakoyun, Süleyman ^b  

^a Kars Harakani State Hospital   (Turkey)

^b KAFKAS UNIVERSITY   (Turkey)

^c HITIT UNIVERSITY   (Turkey)

^d Yedikule Chest Diseases and Thoracic Surgery Training and Research Hospital   (Turkey)

^e Agri Public Hospital   (Turkey)

^f Gaziemir State Hospital   (Turkey)

^g NONE   (Turkey)

Author keywords

Coronary artery disease; No reflow; ST elevation myocardial infarction; Syntax score; Syntax score II

Indexed keywords

GLUCOSE;

ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD CLOT LYSIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HEART EJECTION FRACTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NO REFLOW PHENOMENON; PERCUTANEOUS CORONARY INTERVENTION; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PREDICTION; PREDICTOR VARIABLE; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SYNTAX SCORE; SYNTAX SCORE II; THROMBOLYSIS IN MYOCARDIAL INFARCTION; AGED; CORONARY ANGIOGRAPHY; CORONARY ARTERY BLOOD FLOW; DECISION SUPPORT SYSTEM; DIAGNOSTIC IMAGING; PATHOPHYSIOLOGY; PREDICTIVE VALUE; REPRODUCIBILITY; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

AGED; AREA UNDER CURVE; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY CIRCULATION; DECISION SUPPORT TECHNIQUES; FEMALE; HUMANS; MALE; MIDDLE AGED; NO-REFLOW PHENOMENON; PERCUTANEOUS CORONARY INTERVENTION; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; ROC CURVE; SEVERITY OF ILLNESS INDEX; ST ELEVATION MYOCARDIAL INFARCTION; TREATMENT OUTCOME;

EID: 85021713351     PISSN: 15695794     EISSN: 15730743     Source Type: Journal    
DOI: 10.1007/s10554-017-1200-5     Document Type: Article

References (24)

1. Antman EM, Anbe DT, Armstrong PW et al (2004) ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). Circulation 110:e82–e292
2. Niccoli G, Burzotta F, Galiuto L et al (2009) Myocardial no-reflow in humans. J Am Coll Cardiol 54(4):281–292. doi:10.1016/j.jacc.2009.03.054
3. Ito H, Iwakura K (1998) Assessing the relation between coronary reflow and myocardial reflow. Am J Cardiol 81(12A):8G–12G
4. Morice MC, Serruys PW, Kappetein AP et al (2010) Outcomes in patients with de novo left main disease treated with either percutaneous coronary intervention using paclitaxel-eluting stents or coronary artery bypass graft treatment in the Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial. Circulation 121:2645–2653
5. Farooq V, van Klaveren D, Steyerberg EW et al (2013) Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II. Lancet 381:639–650
6. Şahin DY, Gür M, Elbasan Z et al (2013) SYNTAX score is a predictor of angiographic no-reflow in patients with ST-elevation myocardial infarction treated with a primary percutaneous coronary intervention. Coron Artery Dis 24(2):148–153. doi:10.1097/MCA.0b013e32835c4719
7. Ndrepepa G, Tiroch K, Fusaro M et al (2010) 5-year prognostic value of no-reflow phenomenon after percutaneous coronary intervention in patients with acute myocardial infarction. J Am Coll Cardiol 55:2383–2389
8. Steg PG, James SK et al (2012) ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segmentelevation. Eur Heart J 33(20):2569–2619. doi:10.1093/eurheartj/ehs215
9. Gibson CM, Cannon CP, Murphy SA et al (2002) Relationship of the TIMI myocardial perfusion grades, flow grades, frame count, and percutaneous coronary intervention to longterm outcomes after thrombolytic administration in acute myocardial infarction. Circulation 105:1909–1913
10. Magro M, Nauta ST, Simsek C et al (2012) Usefulness of the SYNTAX score to predict ‘no reflow’ in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. Am J Cardiol 109:601–606
11. Jaffe R, Charron T, Puley G et al (2008) Microvascular obstruction and the no-reflow phenomenon after percutaneous coronary intervention. Circulation 117:3152–3156
12. Topol EJ, Yadav JS (2000) Recognition of the importance of embolization in atherosclerotic vascular disease. Circulation 101:570–580
13. Jaffe R, Charron T, Puley G et al (2008) Microvascular obstruction and the no-reflow phenomenon after percutaneous coronary intervention. Circulation 117(24):3152–3156. doi:10.1161/CIRCULATIONAHA.107.742312
14. Şahin DY et al (2013) SYNTAX score is a predictor of angiographic no-reflow patients with ST-elevation myocardial infarction treated with a primary percutaneous coronary intervention. Coron Artery Dis 24:148–153
15. Fearon WF, Shah M, Ng M et al (2008) Predictive value of the index of microcirculatory resistance in patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol 51:560–565
16. Demirbag R, Yilmaz R, Gur M et al (2005) Lymphocyte DNA damage in patients with acute coronary syndrome and its relationship with severity of acute coronary syndrome. Mutat Res 578:298–307
17. Gupta S, Gupta MM (2016) No reflow phenomenon in percutaneous coronary interventions in ST-segment elevation myocardial infarction. Indian Heart J 68(4):539–551
18. Dragu R, Behar S, Sandach A et al (2006) Should primary percutaneous coronary intervention be the preferred method of reperfusion therapy for patients with renal failure and ST-elevation acute myocardial infarction? Am J Cardiol 97(8):1142–1145
19. Sensoy B, Uzunget SB, Acikgoz S et al (2016) Renal dysfunction on admission predicts no-reflow phenomenon in patients undergoing manual thrombus aspiration during primary percutaneous coronary intervention. Zhonghua Minguo Xin Zang Xue Hui Za Zhi 32(2):185–193
20. Iwakura K, Ito H, Ikushima M et al (2003) Association between hyperglycemia and the no-reflow phenomenon in patients with acute myocardial infarction. J Am Coll Cardiol 41(1):1–7
21. Liang BM, Xu ZB, Yi Q et al (2013) Association of chronic obstructive pulmonary disease with coronary artery disease. Chin Med J 126:3205–3208
22. Konecny T, Somers K, Orban M et al (2010) Interactions between COPD and outcomes after percutaneous coronary intervention. Chest 138:621–627
23. Koseoglu C, Kurmus O, Ertem AG et al (2016) Forced expiratory volume in one second can predict SYNTAX score in patients with chronic obstructive pulmonary disease. Kardiol Pol 74(6):584–590
24. Wang G, Hua Q, Li J et al (2016) Does SYNTAX score II predict poor myocardial perfusion in ST-segment elevation myocardial infarction. Cardiol J 23(3):317–323. doi:10.5603/CJ.a2016.0006